| UPDATE | 01.01 |
| ALLIANCE |
Between - Aventis Pharma Deutschland GmbH - Millennium Pharmaceuticals have signed a $450 million R&D deal. The 2 companies will jointly discover, develop & commercialize drugs to treat inflammatory diseases. They will also jointly develop new drug discovery technologies. In actuality 4 agreements, the five-year $450 million deal includes - (1) Millennium will give Aventis nonexclusive access to its drug discovery technologies in exchange for $200 million in funding over 5 years - (2) Aventis also will make a $250 million equity investment in Millennium by the end of 2001 - (3) & (4) The remaining drug & technology development agreements include joint funding by the 2 companies. Profits from any North American sales will be shared. Out side of the region, Aventis will develop & market any resul ting prodts & make royalty payments to Millennium |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |